Literature DB >> 19831567

A clinical survey of uveitis in HTLV-1 endemic region.

Masaru Miyanaga1, Kentaro Shimizu, Tatsushi Kawaguchi, Kazunori Miyata, Manabu Mochizuki.   

Abstract

PURPOSE: To investigate a clinical survey of uveitis in southern Kyushu of Japan, where human T-lymphotropic virus type 1 (HTLV-1) and toxoplasmosis is highly endemic.
METHODS: The clinical records of patients with uveitis between 1975 and 2007 at Miyata Eye Hospital were reviewed.
RESULTS: A total number of 1338 patients (2012 eyes), consisting of 526 men and 812 women with mean age of 50.5 years old, were analyzed. The most common clinical entity was HTLV-1 uveitis (17.1%), followed by Vogt-Koyanagi-Harada disease (9.9%), sarcoidosis (7.2%), toxoplasmosis (7.1%), Behçet's disease (4.3%) and others. Unclassified uveitis comprised 41.1% in the series. Anterior uveitis was seen in 30.8%, intermediate uveitis in 17.3%, posterior uveitis in 9.3%, and pan-uveitis in 42.6%.
CONCLUSIONS: HTLV-1 uveitis and toxoplasmosis were the major clinical entities in southern Kyushu of Japan. This relates to the high seroprevalence of the infectious agents in this region of Japan.

Entities:  

Mesh:

Year:  2009        PMID: 19831567     DOI: 10.3109/09273940903137667

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  8 in total

1.  Turning a blind eye: HTLV-1-associated uveitis in Indigenous adults from Central Australia.

Authors:  Rusheng Chew; Timothy Henderson; Jaskirat Aujla; Eline Whist; Lloyd Einsiedel
Journal:  Int Ophthalmol       Date:  2017-07-28       Impact factor: 2.031

Review 2.  A new era of uveitis: impact of polymerase chain reaction in intraocular inflammatory diseases.

Authors:  Manabu Mochizuki; Sunao Sugita; Koju Kamoi; Hiroshi Takase
Journal:  Jpn J Ophthalmol       Date:  2016-10-27       Impact factor: 2.447

3.  Antiretroviral activity of 5-azacytidine during treatment of a HTLV-1 positive myelodysplastic syndrome with autoimmune manifestations.

Authors:  Panagiotis T Diamantopoulos; Maria Michael; Olga Benopoulou; Efthymia Bazanis; George Tzeletas; John Meletis; George Vayopoulos; Nora-Athina Viniou
Journal:  Virol J       Date:  2012-01-03       Impact factor: 4.099

4.  Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases.

Authors:  Cimino Luca; Aldigeri Raffaella; Marchi Sylvia; Mastrofilippo Valentina; Viscogliosi Fabiana; Coassin Marco; Soldani Annamaria; Savoldi Luisa; De Fanti Alessandro; Belloni Lucia; Zerbini Alessandro; Parmeggiani Maria; Chersich Matthew; Soriano Alessandra; Salvarani Carlo; Fontana Luigi
Journal:  Int Ophthalmol       Date:  2017-01-09       Impact factor: 2.031

Review 5.  HTLV-1 infection: An emerging risk. Pathogenesis, epidemiology, diagnosis and associated diseases.

Authors:  E Eusebio-Ponce; E Anguita; R Paulino-Ramirez; F J Candel
Journal:  Rev Esp Quimioter       Date:  2019-10-25       Impact factor: 1.553

Review 6.  Updates on HTLV-1 Uveitis.

Authors:  Koju Kamoi; Toshiki Watanabe; Kaoru Uchimaru; Akihiko Okayama; Seiko Kato; Toyotaka Kawamata; Hisako Kurozumi-Karube; Noe Horiguchi; Yuan Zong; Yoshihisa Yamano; Isao Hamaguchi; Yasuhito Nannya; Arinobu Tojo; Kyoko Ohno-Matsui
Journal:  Viruses       Date:  2022-04-12       Impact factor: 5.818

7.  HTLV-1 uveitis.

Authors:  Koju Kamoi; Manabu Mochizuki
Journal:  Front Microbiol       Date:  2012-07-24       Impact factor: 5.640

8.  Relapsing Uveitis due to Human T-lymphotropic Virus Type 1 in a Patient Living With HIV Diagnosed by Metagenomic Deep Sequencing.

Authors:  Varun K Phadke; Jessica G Shantha; Ghazala O'Keefe
Journal:  Open Forum Infect Dis       Date:  2020-03-07       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.